ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,529,000 | -32.7% | 122,961 | -25.9% | 0.00% | 0.0% |
Q3 2016 | $2,272,000 | +174.4% | 165,941 | +48.2% | 0.00% | 0.0% |
Q2 2016 | $828,000 | +29.8% | 112,005 | +5.5% | 0.00% | +100.0% |
Q1 2016 | $638,000 | -74.6% | 106,122 | -74.6% | 0.00% | -66.7% |
Q4 2015 | $2,507,000 | +80.0% | 417,855 | +50.1% | 0.00% | +200.0% |
Q3 2015 | $1,393,000 | -30.1% | 278,432 | +11.7% | 0.00% | -50.0% |
Q2 2015 | $1,994,000 | +10.7% | 249,333 | +10.7% | 0.00% | 0.0% |
Q1 2015 | $1,802,000 | -69.2% | 225,287 | -76.9% | 0.00% | -60.0% |
Q4 2014 | $5,845,000 | +43.1% | 974,163 | +19.3% | 0.01% | +25.0% |
Q3 2014 | $4,085,000 | -58.0% | 816,602 | -49.6% | 0.00% | -63.6% |
Q2 2014 | $9,715,000 | -55.7% | 1,619,040 | -40.9% | 0.01% | -54.2% |
Q1 2014 | $21,925,000 | +43.0% | 2,740,650 | +7.2% | 0.02% | +50.0% |
Q4 2013 | $15,333,000 | +90.5% | 2,555,481 | +471.5% | 0.02% | +77.8% |
Q3 2013 | $8,050,000 | +98.6% | 447,167 | +93.0% | 0.01% | +80.0% |
Q2 2013 | $4,054,000 | – | 231,715 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $82,111,000 | 18.09% |
Consonance Capital Management LP | 5,575,742 | $35,629,000 | 5.39% |
Opaleye Management Inc. | 1,250,000 | $7,988,000 | 4.98% |
Tamarack Advisers, LP | 1,600,000 | $10,224,000 | 3.58% |
Camber Capital Management LP | 5,405,235 | $34,539,000 | 2.02% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 324,636 | $2,074,000 | 1.36% |
Palo Alto Investors LP | 2,248,317 | $14,367,000 | 1.12% |
1492 Capital Management LLC | 202,500 | $1,294,000 | 1.09% |
Geduld E E | 120,100 | $767,000 | 1.05% |
JS Capital Management LLC | 868,700 | $5,551,000 | 1.00% |